Melatonin Replacement Therapy in Pinealectomized Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

February 28, 2019

Conditions
Pineal Tumor
Interventions
DRUG

Melatonin Replacement Therapy

Melatonin (Aché Pharmaceutics, Brazil), 3 mg, administered in the evening, 30 minutes before the usual bedtime, every day for 3 months. After discontinuation of melatonin therapy, patients are followed up for 6 months to assess safety parameters and cardiac autonomic activity.

Trial Locations (1)

05508-000

University of São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT03885258 - Melatonin Replacement Therapy in Pinealectomized Patients | Biotech Hunter | Biotech Hunter